Other
Proceeds From Issuance Of Warrants
Year-over-year, this metric declined by 100.0%, from $23.86M to $0.00. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ1 2022
Last reportedQ4 2025Feb 25, 2026
How to read this metric
An increase indicates successful capital raising or warrant exercise, potentially diluting existing shareholders but strengthening the cash position.
Detailed definition
Cash inflows resulting from the sale or exercise of warrants issued by the company to investors or financial institution...
Peer comparison
Varies significantly by company; often seen in growth-stage firms or those restructuring capital, less common in mature semiconductor firms.
Metric ID:
other_proceeds_from_issuance_of_warrantsHistorical Data
4 years
| FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|
| Value | $0.00 | $0.00 | $95.42M | $0.00 |
| YoY Change | — | — | — | -100.0% |
Range$0.00 – $95.42M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Proceeds From Issuance Of Warrants at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s proceeds from issuance of warrants?
- Revolution Medicines, Inc. (RVMD) reported proceeds from issuance of warrants of $0.00 in Q4 2025.
- How has Revolution Medicines, Inc.'s proceeds from issuance of warrants changed year-over-year?
- Revolution Medicines, Inc.'s proceeds from issuance of warrants decreased by 100.0% year-over-year, from $23.86M to $0.00.
- What does proceeds from issuance of warrants mean?
- Cash received from the issuance or exercise of equity warrants.